Skip to main content

Table 1 Baseline characteristics according to tertiles of plasma fluorescent oxidation products (FlOPs) (N = 917): prospective analysis in the Health Professional Follow-up Study, 1993-1995

From: Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study

Variables

FlOP_360

FlOP_320

FlOP_400

Tertile

1

2

3

1

2

3

1

2

3

Range (FI/ml)

< 184

≥ 184;

< 233

≥ 233

< 356

≥ 356;

< 524

≥ 524

< 49.1

≥ 49.1;

< 62.6

≥ 62.6

N

305

306

306

305

306

306

305

306

306

Age (years)

61.1

61.9

62.3

60.4

62.2

62.6

60.7

62.3

62.2

Body mass index (kg/m2)

25.8

25.8

25.7

25.5

25.9

25.9

25.4

25.9

26.0

Alcohol intake (g/day)a

2.9

8.2

10.0

3.5

8.8

8.6

2.4

8.2

10.4

Physical activity (MET-hours/week)a

26.0

33.6

29.1

27.9

34.2

26.5

28.3

29.8

28.1

Caucasians (%)

92

92

95

91

95

93

93

91

95

Fasting status (≥ 8 h; %)

76.4

56.2

50.3

75.7

56.5

50.7

71.2

59.5

52.3

History of BPH with surgery (%)

1.6

3.6

3.3

1.3

3.3

3.9

2.0

3.6

2.9

History of hypertension (%)

23.3

23.9

31.4

20.3

30.4

27.8

21.3

31.1

26.1

History of diabetes (%)

3.6

2.6

2.9

2.6

3.3

3.3

2.3

3.9

2.9

Current smokers (%)

1.1

6.7

13.0

1.1

9.6

9.4

1.1

4.2

16.5

Past smokers (%)

37.8

49.8

60.8

38.6

55.4

54.4

35.1

50.9

62.7

  1. Variables with normal distribution are shown in mean, unless otherwise specified
  2. aVariables with skew distribution are shown in median
  3. Abbreviations: FlOP = Fluorescent oxidation products, FI = Fluorescent intensity unites, MET = Metabolic equivalent, BPH = Benign prostatic hyperplasia
  4. Bold-faced values indicate statistically significance at P < 0.05 across tertiles of FlOPs